Chemoinformaics analysis of 2-(4-HYDROXYPHENYL)-5,6,7,8-TETRAMETHOXYCHROMEN-4-ONE
| Molecular Weight | 358.346 | nRot | 5 |
| Heavy Atom Molecular Weight | 340.202 | nRig | 18 |
| Exact Molecular Weight | 358.105 | nRing | 3 |
| Solubility: LogS | -3.831 | nHRing | 1 |
| Solubility: LogP | 2.885 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 49.3463 |
| nHD | 1 | BPOL | 27.6057 |
| QED | 0.749 |
| Synth | 2.464 |
| Natural Product Likeliness | 1.133 |
| NR-PPAR-gamma | 0.41 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.556 |
| MDCK | 0.0000252 |
| BBB | 0.016 |
| PPB | 0.83583 |
| VDSS | 0.872 |
| FU | 0.18172 |
| CYP1A2-inh | 0.523 |
| CYP1A2-sub | 0.977 |
| CYP2c19-inh | 0.776 |
| CYP2c19-sub | 0.691 |
| CYP2c9-inh | 0.761 |
| CYP2c9-sub | 0.9 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.861 |
| CYP3a4-inh | 0.501 |
| CYP3a4-sub | 0.614 |
| CL | 4.43 |
| T12 | 0.548 |
| hERG | 0.281 |
| Ames | 0.461 |
| ROA | 0.393 |
| SkinSen | 0.299 |
| Carcinogencity | 0.13 |
| EI | 0.343 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.883 |
| Antiviral | Yes |
| Prediction | 0.880654 |